Ten important orthopedics stories from 2014

Orthopedics Today has highlighted ten important stories from 2014 to keep your practice up-to-date on a multitude of topics in orthopedic medicine.

Stem cell knee injection shown to regenerate meniscus, reduce pain

Results of a randomized, double-blind controlled study in the Journal of Bone and Joint Surgery supported the use of human mesenchymal stem cell for meniscal regeneration and the control of knee pain. Read more.

Zimmer to combine with Biomet

Zimmer Holdings Inc. and Biomet Inc.’s parent company announced the boards of directors for both companies have approved a definitive agreement for Zimmer to purchase Biomet in a cash and stock transaction. Read more.

OARSI releases new guidelines for osteoarthritis treatment

The Osteoarthritis Research Society International released new guidelines for non-surgical management of knee osteoarthritis and highlighted biomechanical interventions, exercise and weight management as some of the appropriate treatments for all patients. Read more.

Intra-articular injection prior to THA linked with infection, early revision

NEW ORLEANS — In a retrospective study using databases for Ontario, Canada, researchers found intra-articular injection 1 year before elective, primary total hip arthroplasty for osteoarthritis was associated with early revision precipitated by infection. Read more.

Platelet-rich plasma more effective for treatment of chronic hip bursitis than cortisone, study finds

Platelet-rich plasma showed clinical superiority over cortisone for patients who received treatment for chronic hip bursitis, according to data presented at the American Academy of Orthopaedics Surgeons Annual Meeting. Read more.


Operative, nonoperative treatment of ACL injury yield similar outcomes

Minimal differences in outcomes and re-injury risks were seen between patients with ACL ruptures treated with or without surgery, according to recently published data. Read more.

Study: Patients with femoral neck fractures have more complications after uncemented hemiarthroplasty

The use of uncemented hemiarthroplasty is associated with more hip reoperations and mechanical complications for patients with femoral neck fractures compared to patients who are treated using cemented hemiarthroplasty, according to a recently published data. Read more.

Biomet issues recall for hip arthroplasty device

Biomet has issued an immediate recall of the Biolox Delta Ceramic Head, a component used in total hip arthroplasty procedures. Read more.

Anterior knee pain: Remember to look up and be aware of structural anomalies

Unfortunately, when an orthopedic surgeon sees a patient with anterior knee pain in the office, he or she normally only focuses on the knee. If we do this we are making a big mistake. Read more.

Three times higher failure rate seen with allograft vs autograft in long-term study

NEW ORLEANS — A prospective, randomized study of young patients who underwent primary ACL reconstruction showed a 26.5% failure rate with fresh frozen tibialis posterior tendon allograft and a 8.5% failure rate with hamstring autograft at a 10-year minimum follow-up. Read more.

Orthopedics Today has highlighted ten important stories from 2014 to keep your practice up-to-date on a multitude of topics in orthopedic medicine.

Stem cell knee injection shown to regenerate meniscus, reduce pain

Results of a randomized, double-blind controlled study in the Journal of Bone and Joint Surgery supported the use of human mesenchymal stem cell for meniscal regeneration and the control of knee pain. Read more.

Zimmer to combine with Biomet

Zimmer Holdings Inc. and Biomet Inc.’s parent company announced the boards of directors for both companies have approved a definitive agreement for Zimmer to purchase Biomet in a cash and stock transaction. Read more.

OARSI releases new guidelines for osteoarthritis treatment

The Osteoarthritis Research Society International released new guidelines for non-surgical management of knee osteoarthritis and highlighted biomechanical interventions, exercise and weight management as some of the appropriate treatments for all patients. Read more.

Intra-articular injection prior to THA linked with infection, early revision

NEW ORLEANS — In a retrospective study using databases for Ontario, Canada, researchers found intra-articular injection 1 year before elective, primary total hip arthroplasty for osteoarthritis was associated with early revision precipitated by infection. Read more.

Platelet-rich plasma more effective for treatment of chronic hip bursitis than cortisone, study finds

Platelet-rich plasma showed clinical superiority over cortisone for patients who received treatment for chronic hip bursitis, according to data presented at the American Academy of Orthopaedics Surgeons Annual Meeting. Read more.


PAGE BREAK

Operative, nonoperative treatment of ACL injury yield similar outcomes

Minimal differences in outcomes and re-injury risks were seen between patients with ACL ruptures treated with or without surgery, according to recently published data. Read more.

Study: Patients with femoral neck fractures have more complications after uncemented hemiarthroplasty

The use of uncemented hemiarthroplasty is associated with more hip reoperations and mechanical complications for patients with femoral neck fractures compared to patients who are treated using cemented hemiarthroplasty, according to a recently published data. Read more.

Biomet issues recall for hip arthroplasty device

Biomet has issued an immediate recall of the Biolox Delta Ceramic Head, a component used in total hip arthroplasty procedures. Read more.

Anterior knee pain: Remember to look up and be aware of structural anomalies

Unfortunately, when an orthopedic surgeon sees a patient with anterior knee pain in the office, he or she normally only focuses on the knee. If we do this we are making a big mistake. Read more.

Three times higher failure rate seen with allograft vs autograft in long-term study

NEW ORLEANS — A prospective, randomized study of young patients who underwent primary ACL reconstruction showed a 26.5% failure rate with fresh frozen tibialis posterior tendon allograft and a 8.5% failure rate with hamstring autograft at a 10-year minimum follow-up. Read more.